Nanobiotechnology and Nanomedicine Companies

Nanosens uses nanotechnologies to make smart, portable and inexpensive sensing systems for ultrasensitive and rapid detection of biological and chemical species.

A nanotechnology-based platform for single molecule identification and digital quantification. The NanoString™ system uniquely barcodes individual target molecules, scans them, and delivers a literal inventory of target molecules in the biological sample.

NanoTemper Technologies GmbH, a Spin-Off of the Ludwig-Maximilians-University Munich, was founded in May 2008 in order to provide analytical services to pharmaceutical industry, biotechnology and research institues.

Nicoya is a nanotechnology company developing novel sensor products. The company's flagship product is OpenSPR - a compact, sensitive, and affordable surface plasmon resonance instrument for molecular analysis.

Oxford Nanopore Technologies Ltd is developing nanopore technology, a revolutionary method of molecular detection and analysis with potential applications in DNA sequencing, diagnostics, drug development and defence.

Combining recent advances in nanofabrication, biochemistry, molecular biology, surface chemistry and optics, the company has created a powerful technology platform called single molecule, real-time, or SMRT, technology. SMRT technology enables real-time analysis of biomolecules with single molecule resolution, which has the potential to transform our understanding of biological systems by providing a window into these systems that has not previously been open for scientific study.

A genomics company that has developed the world's first light-powered microtransponders and nanotransponders for performing nucleic acid-based assays.

Develops and sells patented high performance, injection-molded nanospray devices for mass spectrometry applications in drug discovery, clinical diagnostics and homeland security.

Promega's products are used in life science research, particularly in genomics, proteomics, and cellular analysis to support molecular diagnostics and human identification.

A provider of innovative technologies and products for preanalytical sample preparation and molecular diagnostics solutions such as the HiLight Array System that uses Resonance Light Scattering (RLS), a technology based on the optical light scattering properties of nano-sized metal colloid particles.

Quanterix Corporation is developing a novel platform for single molecule analysis that will bring an unprecedented level of sensitivity, precision, and assay robustness to clinical diagnostics, drug development, and life science research.

Randox Food Diagnostics is a division of Randox Laboratories who have 30 years experience in the diagnostic market and a devoted research and development team. Randox Food Diagnostics is a dedicated company responsible for the distribution of Randox drug residue kits, wine testing kits and analysers worldwide. Randox Food Diagnostics incorporate several market related products dedicated to the food, wine and beverage industries. Randox uses in house developed antibodies and conjugates for a wide range of their screening products including the patented Biochip Array Technology (multiplex screening platform).

Silicon Biosystems has developed a set of proprietary solutions called lab-on-a-chip technologies, targeted at miniaturized cell-biology testing. Silicon Biosystems exploits the microelectronics potential in order to produce miniaturized cellular biology laboratories.

Sphere is commercializing picodroplet technology from Cambridge University that can perform thousands of simultaneous reactions on single cells and molecules contained within aqueous droplets, fractions of a millimeter in size. This platform enables diverse applications including: miniaturized profiling of drug candidates, generation of new biocatalysts and identification of novel algal strains.

T2 Biosystems is creating a new generation of lab-quality diagnostic tools. Its technology is based on superparamagnetic nanoparticles. NanoDx particles have a superparamagnetic metal core surrounded by a polymer layer decorated by multiple analyte-specific binding agents. This nanoparticle platform can be used with a variety of binding agents such as antibodies, nucleic acids and small molecules.

uFluidix develops and manufacturing Point of Care Diagnostic devices and cartridges which uses microfluidic and nanotechnology.

Offers new culture and exposure systems for in vitro studies of gases or complex mixtures. The VITROCELL modules offer new possibilities for the characterization of the effects of airborne substances such as gases nanoparticles and complex mixtures.

The company develops Surface Plasmon Resonance (SPR) biosensors to analyze macromolecular interactions in real-time and label-free.